Cambridge Investment Research Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.87M Sell
76,685
-17,432
-19% -$424K 0.01% 1483
2025
Q1
$1.95M Buy
94,117
+839
+0.9% +$17.4K 0.01% 1372
2024
Q4
$2.2M Sell
93,278
-16,318
-15% -$384K 0.01% 1298
2024
Q3
$2.81M Sell
109,596
-2,214
-2% -$56.7K 0.01% 1118
2024
Q2
$2.63M Sell
111,810
-3,574
-3% -$83.9K 0.01% 1105
2024
Q1
$3.32M Sell
115,384
-8,501
-7% -$244K 0.01% 977
2023
Q4
$4.07M Sell
123,885
-76,479
-38% -$2.51M 0.02% 806
2023
Q3
$5.58M Sell
200,364
-9,782
-5% -$273K 0.03% 603
2023
Q2
$7.16M Sell
210,146
-7,679
-4% -$262K 0.03% 492
2023
Q1
$6.55M Buy
217,825
+12,532
+6% +$377K 0.03% 510
2022
Q4
$5.8M Sell
205,293
-20,476
-9% -$578K 0.03% 546
2022
Q3
$7.42M Buy
225,769
+11,969
+6% +$393K 0.04% 409
2022
Q2
$6.73M Sell
213,800
-4,188
-2% -$132K 0.04% 460
2022
Q1
$10M Sell
217,988
-44,596
-17% -$2.05M 0.05% 373
2021
Q4
$16.1M Sell
262,584
-26,276
-9% -$1.61M 0.07% 257
2021
Q3
$21.6M Sell
288,860
-27,851
-9% -$2.08M 0.11% 195
2021
Q2
$29.3M Sell
316,711
-2,031
-0.6% -$188K 0.14% 146
2021
Q1
$28.3M Buy
318,742
+63,718
+25% +$5.65M 0.15% 135
2020
Q4
$23.8M Buy
255,024
+13,869
+6% +$1.29M 0.14% 147
2020
Q3
$15.4M Buy
241,155
+114,168
+90% +$7.27M 0.1% 202
2020
Q2
$6.62M Sell
126,987
-2,785
-2% -$145K 0.05% 349
2020
Q1
$4.06M Buy
129,772
+1,505
+1% +$47.1K 0.04% 427
2019
Q4
$4.3M Buy
128,267
+1,775
+1% +$59.5K 0.03% 517
2019
Q3
$3.73M Buy
126,492
+7,687
+6% +$227K 0.03% 530
2019
Q2
$4.1M Buy
118,805
+32,961
+38% +$1.14M 0.04% 473
2019
Q1
$2.82M Buy
85,844
+11,330
+15% +$373K 0.03% 582
2018
Q4
$1.79M Sell
74,514
-630
-0.8% -$15.1K 0.02% 677
2018
Q3
$2.51M Buy
75,144
+21,583
+40% +$722K 0.02% 597
2018
Q2
$1.56M Buy
53,561
+45,344
+552% +$1.32M 0.02% 753
2018
Q1
$212K Buy
+8,217
New +$212K ﹤0.01% 1926